Search Orphan Drug Designations and Approvals
-
Generic Name: | interleukin-1 receptor antagonist (IL-1Ra, sequence-homologous anakinra) |
---|---|
Date Designated: | 08/07/2018 |
Orphan Designation: | Treatment of Bronchiolitis Obliterans |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Onspira Therapeutics, Inc., a wholly owned subsidiary of Sumitomo Pharma America, Inc. 101 Lindenwood Drive Suite 400 Malvern, Pennsylvania 19355 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-